EFA response to EMA consultation on allergen product development in low-sized populations
The European Medicines Agency (EMA) launched a public consultation on the basis of a concept paper for a ‘Guideline for allergen products development...
EFA Response to EMA Public Consultation on Patient Registries
The European Medicines Agency (EMA) launched a public consultation on the basis of a discussion paper focusing on the “use of patient disease registries...
EFA response to WHO invitation for public comment: Global Action Plan for Healthy Lives and Well-being
EFA provided input in the call for comments organised by the World Health Organisation (WHO), regarding strengthening collaboration among multilateral...
Medical Devices Regulation - Guidance on graphical symbols
The Medical Devices Regulation (2017/745 EU) entered into force in 2017 with rules being applicable after a transitional period ending in spring 2020....
EFSA publishes guidance on the use of threshold of toxicological concern approach in food safety assessment
The European Food Safety Authority (EFSA) carried out a public consultation to receive input from the scientific community and all interested parties on...
EFA at EFPIA Annual Conference
EFA Director Susanna Palkonen attended the annual networking event of the European Federation of Pharmaceutical Industries Associations (EFPIA). The event...
Medicines for rare diseases and children conference
On June 17th, the European Commission Directorate General for Health and Food Safety (DG SANTE) organised a conference on medicines for rare diseases and...
EFA in the EU Chemicals Policy 2030 conference
EFA was present in the conference on EU chemicals policy 2030, organised by the European Chemicals Agency (ECHA) in Brussels on 27-28 June. On the 1st...
EPSCO Council adopts tougher rules for Persistent Organic Pollutants (POPs)
On 13th June, the Council adopted stricter rules on the so-called Persistent Organic Pollutants (POPs), a list of chemical substances which are dangerous...
United Nations: Tobacco Control as Human Rights and Ministerial meeting on sustainable development
In light of the 41st session of the United Nations (UN) Human Rights Council which took place from June 14th to July 12th in Geneva, Switzerland, the Secretariat...
MyAirCoach presented at key medicines conference
On Friday 14th June, EFA was invited to speak at the Annual Medicines Europe and International Generic and Biosimilar Medicines Association Conference...
EFA meets patient group in Georgia
During the last five years, the EFA Capacity Building project has provided our members with tools to fill gaps in recognition and funding, but also helped...
First electronic health records of patients exchanged between EU countries
From late June, first health records of patients are exchanged in the EU thanks to the cross-border electronic health services. As of now, doctors in Luxembourg...
Catering staff knows too little about food allergies
A new study on restaurant staff reveals low levels of food allergy knowledge and negative attitudes about serving people with food allergies. The study...
Being prepared for holidays and festivals with allergy, asthma and eczema
Summer is for holidays. To make them as relaxing as possible, EFA members Allergy UK and Asthma-Allergy Denmark have collected tips on how to prepare for...
EFA at first ever online congress of allergic and respiratory patients in Spain
The Spanish Federation of Allergy and Airways Diseases Patients’ Associations (FENAER) inaugurated on the 8th of July in Madrid, Spain, the first Online...
Easing the economic burden of asthma
EFA Member, Asthma Society of Ireland, has published a new research confirming the enormity of the asthma burden and showing up-to-date figures on the...
SAVE THE DATE: World Atopic Eczema Day 14th September
On September 14th, EFA together with Global Skin we are marking the 2nd World Atopic Eczema Day with the theme BENEATH THE SURFACE to raise awareness and...
Allergy included for the first time in the International Classification of Diseases
The 72nd WHO World Health Assembly (WHA) held in Geneva late May adopted a revision of the International Classification of Diseases (ICD) that includes...
We spoke about adrenaline auto-injectors at the 2019 EAACI 2019 Congress
EFA participated in the European Academy of Allergy and Clinical Immunology (EAACI) Congress, celebrated in Lisbon from 1st to 5th June. The Congress is...